Primaquine

"Primaquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)

Descriptor ID

D011319

MeSH Number(s)

D03.438.810.050.650

Concept/Terms

Primaquine

Primaquine Phosphate

Primacin

Primaquine Diphosphate

Below are MeSH descriptors whose meaning is more general than "Primaquine".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 2-Ring [D03.438]
Quinolines [D03.438.810]
Aminoquinolines [D03.438.810.050]
Primaquine [D03.438.810.050.650]

Below are MeSH descriptors whose meaning is related to "Primaquine".

Below are MeSH descriptors whose meaning is more specific than "Primaquine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Primaquine" by people in Harvard Catalyst Profiles by year, and whether "Primaquine" was a major or minor topic of these publication.

Bar chart showing 17 publications over 13 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	1	2
1996	1	0	1
1999	1	0	1
2000	1	0	1
2001	0	1	1
2006	1	0	1
2007	0	1	1
2009	1	0	1
2011	1	0	1
2014	1	0	1
2016	1	1	2
2017	0	1	1
2019	1	2	3

Below are the most recent publications written about "Primaquine" by people in Profiles.

Targeting liver stage malaria with metformin. JCI Insight. 2019 12 19; 4(24).

View in: PubMed
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019 12 06; 10(1):5595.

View in: PubMed
Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030. Malar J. 2019 Mar 12; 18(1):75.

View in: PubMed
Case report of Plasmodium ovale curtisi malaria in Sri Lanka: relevance for the maintenance of elimination status. BMC Infect Dis. 2017 04 24; 17(1):307.

View in: PubMed
Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda. Sci Rep. 2016 05 20; 6:26330.

View in: PubMed
Difference of the clinical course and outcome between dapsone-induced methemoglobinemia and other toxic-agent-induced methemoglobinemia. Clin Toxicol (Phila). 2016 Aug; 54(7):581-4.

View in: PubMed
Interactive medical case. A chilly fever. N Engl J Med. 2014 Oct 16; 371(16):e24.

View in: PubMed
Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations. PLoS Med. 2014 Aug; 11(8):e1001704.

View in: PubMed
Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti. Am J Trop Med Hyg. 2014 Aug; 91(2):412-4.

View in: PubMed
Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies. BMJ Open. 2014 May 14; 4(5):e004664.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Am J Trop Med Hyg
Clin Infect Dis
Malar J
Ann Intern Med
Nat Commun
N Engl J Med
J Travel Med
J Pharm Biomed Anal
BMJ Open
Antimicrob Agents Chemother